PharmaGossip: Glaxo Seeks $1.5 Billion in AIDS Drug Trial Against .
Abbott, in December 2003, quadrupled the price of its AIDS medicine Norvir, a boosting agent for other HIV medicines such as Abbott's Kaletra. The price increase meant that other drugmakers that used Norvir in their medicines couldn't ...
Blog Content